FSD Pharma (HUGE) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period U.S. election: Tesla and the EV sector are on watch for volatility this weekNovember 3, 2024 | msn.comNvidia: Self-Driving Vehicles Are An Important Proof PointOctober 31, 2024 | seekingalpha.comIt's Time To Buy Baidu AgainOctober 25, 2024 | seekingalpha.comTesla: Q3 Deliveries Not Bad At AllOctober 8, 2024 | seekingalpha.comTesla: Ignore The Delivery Miss Noise, Focus On 'We, Robot'October 3, 2024 | seekingalpha.comWhat Seeking Alpha analysts think about the Tesla robotaxi eventOctober 3, 2024 | seekingalpha.comEV watch: Tesla deliveries, robotaxi musings, and soaring deliveries in ChinaOctober 1, 2024 | seekingalpha.comTesla Is Ready To Complete A Cup And Handle, And Continue This Breakout (Technical Analysis)September 25, 2024 | seekingalpha.comFTC head Lina Khan fighting Big Tech, Big Pharma and Big GroceriesSeptember 24, 2024 | msn.comFederal regulator hauls huge drug middlemen into court over insulin pricesSeptember 24, 2024 | yahoo.comTesla falls 6% as investors weigh robotaxi developmentsAugust 23, 2024 | msn.comWhy FSD Pharma Stock Is Seeing Huge GainsAugust 9, 2024 | benzinga.comFSD Pharma Inc (0K9.MU)July 21, 2024 | nz.finance.yahoo.comBig Pharma’s focus on profit is behind medicine shortages, superbug threatMay 28, 2024 | msn.comMedicus Pharma eyes IPO with 'groundbreaking' SkinJect patch in the pipelineMay 13, 2024 | bizjournals.comU.S. factory orders rise 1.6% M/M in March, meeting consensusMay 2, 2024 | msn.comMerck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly BeatApril 26, 2024 | msn.comFSD Pharma Provides Update from Celly Nu’s Partnership with Six+One for unbuzzd(TM)April 25, 2024 | finance.yahoo.comFSD Pharma Inc.: FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and ProductsApril 17, 2024 | finanznachrichten.deFSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and ProductsApril 17, 2024 | finance.yahoo.comSam Bankman-Fried gets 25 years in prison for fraud and money laundering at FTX, ordered to pay $11B in forfeitureMarch 30, 2024 | techcrunch.comHUGE Apr 2024 2.000 putMarch 16, 2024 | finance.yahoo.comFSD Pharma Inc.: FSD Pharma Announces Debt SettlementFebruary 28, 2024 | finanznachrichten.deBiotech Company Develops Inebriation Remedy Beverage 'UNBUZZD'February 26, 2024 | msn.comFSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One BasisNovember 7, 2023 | finance.yahoo.comFSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well ToleratedSeptember 18, 2023 | finance.yahoo.comFSD Pharma Selected to Present its Phase 1 Data on Lucid-MS at MSMilan 2023 – 9th Joint ECTRIMS-ACTRIMS Meeting for October 11-13, 2023August 15, 2023 | finance.yahoo.comInvestmentPitch Media Video Features FSD Pharma’s Definitive Agreement Granting Exclusive Rights for Launch of UNBUZZD, a Revolutionary Rapid Alcohol Detoxification DrinkAugust 3, 2023 | finance.yahoo.comInvestmentPitch Media Video Discusses FSD Pharma’s Granting of Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology to Celly NutritionJune 23, 2023 | finance.yahoo.comFSD Pharma Announces Agreement To Grant Exclusive Rights To Recreational Alcohol Misuse TechnologyJune 20, 2023 | msn.comFSD Pharma Announces Agreement to Grant Exclusive Rights to Revolutionary Recreational Alcohol Misuse TechnologyJune 20, 2023 | finance.yahoo.comFSD Pharma Appoints Former Ontario Minister of Health Doctor Eric Hoskins to Board of DirectorsMay 25, 2023 | finance.yahoo.comFSD Pharma Inc. (HUGE.CN)May 13, 2023 | finance.yahoo.comFSD Pharma Awarded $2.81 Million in Cost Awards From Dr. Raza BokhariMay 11, 2023 | finance.yahoo.comPromising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing CompletedMay 10, 2023 | msn.comFSD Pharma Completes Dosing of First Cohort in Phase I Clinical Trial of Lucid-MS, a New Drug Candidate for the Treatment of Multiple Sclerosis: Safety Review Committee Recommends Commencing Dosing of Second CohortMay 10, 2023 | finance.yahoo.comDynamic Duo of Celsius Holdings Fame join FSD Pharma calling Medical Product under Development "Unique and Disruptive"April 19, 2023 | benzinga.comFSD Pharma Announces Plan to Spin-Out Subsidiary as Distribution to Shareholders; Shareholder Meeting Scheduled for June 29, 2023April 12, 2023 | finance.yahoo.comIIROC Trading Halt - HUGEApril 12, 2023 | finance.yahoo.comIIROC Trade Resumption - HUGEApril 12, 2023 | finance.yahoo.comFSD Pharma Presenting Two Scientific Posters on Preclinical Toxicology and Efficacy Data of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2023 ForumFebruary 21, 2023 | finance.yahoo.comFSD Pharma Regains Compliance with NASDAQ Continued Listing RequirementsFebruary 15, 2023 | finance.yahoo.comFSD Pharma receives regulatory clearance for proposed Phase 1 clinical trial of multiple sclerosis drug candidate Lucid-MSFebruary 7, 2023 | proactiveinvestors.comFSD Pharma submits clinical trial application for its multiple sclerosis treatment candidate Lucid-MSJanuary 17, 2023 | proactiveinvestors.comFSD Pharma submits its phase-1 Clinical Trial Application for Lucid-MS (Lucid-21-302) for first-in-human safety and tolerability investigationJanuary 17, 2023 | finance.yahoo.comTesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On MondayJanuary 9, 2023 | msn.comFSD Pharma incorporates new subsidiary to capitalize on drug development incentives in AustraliaJanuary 9, 2023 | proactiveinvestors.comFSD Pharma Inc Incorporates New Subsidiary to Capitalize on Drug Development Incentives in AustraliaJanuary 9, 2023 | financialpost.comFSD Pharma to Attend 41st Annual J.P. Morgan Healthcare Conference 2023January 6, 2023 | finance.yahoo.comFDA and Health Canada Clear IND for FSD Pharma to Proceed with Phase 2 Trial of FSD201 for Nociplastic Pain Associated with Idiopathic Mast Cell Activation SyndromeSeptember 6, 2022 | finance.yahoo.com Get FSD Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HUGE and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now HUGE Media Mentions By Week HUGE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HUGE News Sentiment▼0.000.64▲Average Computer and Technology News Sentiment HUGE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HUGE Articles This Week▼00▲HUGE Articles Average Week Get FSD Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HUGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SHOP News CSU News DSG News OTEX News KXS News LSPD News DCBO News ENGH News DND News CMG News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CNSX:HUGE) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FSD Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share FSD Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
